skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [2];  [1];  [3];  [2];  [4];  [5];  [6];  [7];  [7];  [8]
  1. Department of Psychogeriatrics, Tokyo Institute of Psychiatry 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585 (Japan)
  2. Department of Molecular Neurobiology, Tokyo Institute of Psychiatry 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585 (Japan)
  3. Zikei hospital 100-2 Urayasuhonmachi, Okayama-shi, Okayama 702-8508 (Japan)
  4. Department of Neuroscience, Osaka City University School of Medicine, 1-4-3 Asahimachi, Abenoku, Osaka 545-8585 (Japan)
  5. Greater Manchester Neurosciences Centre, University of Manchester, Hope Hospital, Salford M6 8HD (United Kingdom)
  6. Department of Laboratory Medicine and Pathology, Tokyo Metropolitan Matsuzawa Hospital, 2-1-1 Kamikitazawa, Setagaya-ku, Tokyo 156-0057 (Japan)
  7. Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 21 Karimata, Yazako, Nagakute-cho, Aichi-gun, Aichi 480-1195 (Japan)
  8. Department of Neuropsychiatry, National Shimofusa Mental Hospital, Chiba 266-0007 (Japan)

Ubiquitin-positive tau-negative neuronal cytoplasmic inclusions and dystrophic neurites are common pathological features in frontotemporal lobar degeneration (FTLD) with or without symptoms of motor neuron disease and in amyotrophic lateral sclerosis (ALS). Using biochemical and immunohistochemical analyses, we have identified a TAR DNA-binding protein of 43 kDa (TDP-43), a nuclear factor that functions in regulating transcription and alternative splicing, as a component of these structures in FTLD. Furthermore, skein-like inclusions, neuronal intranuclear inclusions, and glial inclusions in the spinal cord of ALS patients are also positive for TDP-43. Dephosphorylation treatment of the sarkosyl insoluble fraction has shown that abnormal phosphorylation takes place in accumulated TDP-43. The common occurrence of intracellular accumulations of TDP-43 supports the hypothesis that these disorders represent a clinicopathological entity of a single disease, and suggests that they can be newly classified as a proteinopathy of TDP-43.

OSTI ID:
20857924
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 351, Issue 3; Other Information: DOI: 10.1016/j.bbrc.2006.10.093; PII: S0006-291X(06)02318-7; Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons
Journal Article · Thu Aug 01 00:00:00 EDT 2013 · Experimental Cell Research · OSTI ID:20857924

The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity
Journal Article · Fri Aug 24 00:00:00 EDT 2012 · Biochemical and Biophysical Research Communications · OSTI ID:20857924

Imbalance of mitochondrial dynamics in Drosophila models of amyotrophic lateral sclerosis
Journal Article · Fri Dec 09 00:00:00 EST 2016 · Biochemical and Biophysical Research Communications · OSTI ID:20857924